Omniab, INC. (OABI) — SEC Filings
Latest SEC filings for Omniab, INC.. Recent 144 filing on Apr 8, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Omniab, INC. on SEC EDGAR
Overview
Omniab, INC. (OABI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 144 filed on Apr 8, 2026: Matthew W. Foehr, reporting for OmniAb, Inc., filed a Form 144 on April 7, 2026, indicating a proposed sale of securities. The filing details the mailing and business addresses for both the reporting individual and the company, OmniAb, Inc., located in La Jolla and Emeryville, California, respective
Sentiment Summary
Across 6 filings, the sentiment breakdown is: 6 neutral. The dominant filing sentiment for Omniab, INC. is neutral.
Filing Type Overview
Omniab, INC. (OABI) has filed 3 4, 3 144 with the SEC between Apr 2026.
Recent Filings (6)
- 144 Filing — 144 · Apr 8, 2026
- 4 Filing — 4 · Apr 8, 2026
-
OmniAb, Inc. (OMAB) Files Form 144 for Security Sale
— 144 · Apr 8, 2026 Risk: medium
Matthew W. Foehr, reporting for OmniAb, Inc., filed a Form 144 on April 7, 2026, indicating a proposed sale of securities. The filing details the mailing and bu -
OmniAb, Inc. Insider Reports Securities Ownership Change
— 4 · Apr 8, 2026 Risk: low
On April 7, 2026, Kurt A. Gustafson, a reporting person associated with OmniAb, Inc., reported a change in beneficial ownership of securities. The filing detail - 4 Filing — 4 · Apr 8, 2026
-
OmniAb, Inc. Files Form 144 for Proposed Securities Sale
— 144 · Apr 8, 2026 Risk: medium
Charles S. Berkman, reporting for OmniAb, Inc., filed a Form 144 on April 7, 2026, indicating a proposed sale of securities. The filing provides mailing and bus
Risk Profile
Risk Assessment: Of OABI's 3 recent filings, 0 were flagged as high-risk, 2 as medium-risk, and 1 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- Matthew W. Foehr
- Kurt A. Gustafson
- 0001462354
- Charles S. Berkman
- 0001392266
Top Tags
insider-filing (3) · proposed-sale (1) · sec-form-144 (1) · ownership-change (1) · securities-sale (1)
Frequently Asked Questions
What are the latest SEC filings for Omniab, INC. (OABI)?
Omniab, INC. has 6 recent SEC filings from Apr 2026, including 3 4, 3 144. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of OABI filings?
Across 6 filings, the sentiment breakdown is: 6 neutral. The dominant sentiment is neutral.
Where can I find Omniab, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Omniab, INC. (OABI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Omniab, INC.?
Financial highlights for Omniab, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for OABI?
Investment thesis data for OABI will be available once enriched filings are processed.
Who are the key executives at Omniab, INC.?
Key executives identified across Omniab, INC.'s filings include Matthew W. Foehr, Kurt A. Gustafson, 0001462354, Charles S. Berkman, 0001392266.
What are the main risk factors for Omniab, INC. stock?
Of OABI's 3 assessed filings, 0 were flagged high-risk, 2 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Omniab, INC.?
Forward guidance and predictions for Omniab, INC. are extracted from SEC filings as they are enriched.